コンテンツにスキップ
CAT Logo 2
  • カテニオンについて
  • サービス内容
  • データ・サイエンス
  • インサイト
  • キャリア
  • 問い合わせ
  • 日本語
    • 英語
    • 繁体中国語
pexels stacey gabrielle koenitz rozells 2425011
PrevPreviousValue-Based Pharma R&D Productivity: Is There A Scalable Model?
NextWhat is InnovationNext

Era of Best in Class

  • 11月 19, 2014
Download Article
Go back to the overview

Discover Other Articles

Pharma Spreads Its Bets On Multiple Modalities In Advanced Products

Pharma Spreads Its Bets On Multiple Modalities In Advanced Products

7月 5, 2022
Companies such as No…
Read This Article
2021 Global Biopharma R&D Productivity And Growth Ranking

2021 Global Biopharma R&D Productivity And Growth Ranking

5月 20, 2022
A turbulent 2021: we…
Read This Article
2020 Global Biopharma R&D Productivity And Growth Ranking

2020 Global Biopharma R&D Productivity And Growth Ranking

3月 25, 2021
THE DECREASE IN OVER…
Read This Article
Predicting Success of Clinical Trials

Predicting Success of Clinical Trials

3月 5, 2021
In spite of huge pro…
Read This Article
Predicting Success of Phase III Trials in Oncology

Predicting Success of Phase III Trials in Oncology

12月 22, 2020
We developed a model…
Read This Article
The Architecture Of A Blockbuster

The Architecture Of A Blockbuster

11月 17, 2020
Blockbuster status h…
Read This Article
2019 Rare Diseases and Orphan Products Breakthrough Summit

2019 Rare Diseases and Orphan Products Breakthrough Summit

2月 25, 2020
The aim of this meet…
Read This Article
2019 Global Biopharma R&D Productivity And Growth Ranking

2019 Global Biopharma R&D Productivity And Growth Ranking

2月 14, 2020
An analysis of the R…
Read This Article
Digital Transformation in Drug Discovery

Digital Transformation in Drug Discovery

6月 3, 2019
Digital technology i…
Read This Article
2018 Global Biopharma R&D Productivity And Growth Ranking

2018 Global Biopharma R&D Productivity And Growth Ranking

1月 28, 2019
In 2017, R&D product…
Read This Article
See All News & Insights
Go back to the overview

Discover Other Articles

Pharma Spreads Its Bets On Multiple Modalities In Advanced Products

Pharma Spreads Its Bets On Multiple Modalities In Advanced Products

7月 5, 2022
Companies such as No…
Read This Article
2021 Global Biopharma R&D Productivity And Growth Ranking

2021 Global Biopharma R&D Productivity And Growth Ranking

5月 20, 2022
A turbulent 2021: we…
Read This Article
2020 Global Biopharma R&D Productivity And Growth Ranking

2020 Global Biopharma R&D Productivity And Growth Ranking

3月 25, 2021
THE DECREASE IN OVER…
Read This Article
Predicting Success of Clinical Trials

Predicting Success of Clinical Trials

3月 5, 2021
In spite of huge pro…
Read This Article
Predicting Success of Phase III Trials in Oncology

Predicting Success of Phase III Trials in Oncology

12月 22, 2020
We developed a model…
Read This Article
The Architecture Of A Blockbuster

The Architecture Of A Blockbuster

11月 17, 2020
Blockbuster status h…
Read This Article
2019 Rare Diseases and Orphan Products Breakthrough Summit

2019 Rare Diseases and Orphan Products Breakthrough Summit

2月 25, 2020
The aim of this meet…
Read This Article
2019 Global Biopharma R&D Productivity And Growth Ranking

2019 Global Biopharma R&D Productivity And Growth Ranking

2月 14, 2020
An analysis of the R…
Read This Article
Digital Transformation in Drug Discovery

Digital Transformation in Drug Discovery

6月 3, 2019
Digital technology i…
Read This Article
2018 Global Biopharma R&D Productivity And Growth Ranking

2018 Global Biopharma R&D Productivity And Growth Ranking

1月 28, 2019
In 2017, R&D product…
Read This Article
See All News & Insights

カテニオン

カテニオンは、製薬会社がより革新的で効果的な戦略を実行するのを支援することに専念する経営コンサルティング会社です
Envelope Phone-square-alt Linkedin

サイトマップ

  • カテニオンについて
  • サービス内容
  • データ・サイエンス
  • インサイト
  • キャリア
  • 問い合わせ
  • 日本語
    • 英語
    • 繁体中国語
メニュー
  • カテニオンについて
  • サービス内容
  • データ・サイエンス
  • インサイト
  • キャリア
  • 問い合わせ
  • 日本語
    • 英語
    • 繁体中国語

追加

  • クッキーポリシー
  • プライバシーに関する声明
  • Imprint
  • 免責事項
メニュー
  • クッキーポリシー
  • プライバシーに関する声明
  • Imprint
  • 免責事項

ベルリン

Catenion GmbH

Headquarters EU
Münzstraße 18
10178 Berlin
ドイツ

電話: +49 30 20 63 33 56

メール: berlin@catenion.com

ボストン

Catenion Inc.

Headquarters USA
90 Canal St., 4th Floor
Boston, MA 02114
アメリカ

電話: +1 617 459 2269

メール:boston@catenion.com

ロンドン

Satellite Office Catenion GmbH

180 Piccadilly
London W1J 9HF
イギリス

電話: +44 20 7917 9511

メール: london@catenion.com

東京

Satellite Office Catenion
GmbH

Otemachi 1st Square East Tower
1-5-1 Otemachi, Chiyoda-ku
Tokyo, Japan, 100-0004

電話: +81(3) 5219 1200

メール: tokyo@catenion.com

2022 © Catenion. 全著作権所有。

2022 © Catenion. 全著作権所有。

Manage Cookie Consent
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
Manage options Manage services Manage vendors Read more about these purposes
View preferences
{title} {title} {title}